Sale!

CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test

4,400 د.إ

-21%

The CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CRBN gene. These mutations are associated with a rare form of intellectual disability, known as Autosomal Recessive Mental Retardation Type 2. This condition is characterized by significant cognitive, social, and developmental delays, and it is inherited in an autosomal recessive pattern, meaning that an affected individual receives a defective gene from each parent.

The test is conducted through a comprehensive analysis of the patient’s DNA, specifically targeting the CRBN gene to detect any anomalies or mutations that may be responsible for the condition. This genetic test is crucial for early diagnosis and management of the disorder, allowing for tailored therapeutic interventions and support to improve the quality of life for affected individuals and their families.

The cost of the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CRBN gene and provide reliable results. Early detection through this test can be a critical step in managing the condition effectively, offering insights into potential treatments and supportive measures.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test

Welcome to DNA Labs UAE, where we offer the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test. This test is designed to diagnose individuals with mental retardation and developmental delay caused by mutations in the CRBN gene.

Test Details

The CRBN gene is associated with mental retardation, autosomal recessive type 2 (MRT2). MRT2 is a rare genetic disorder characterized by intellectual disability and developmental delay. It is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for their child to develop the condition.

Our genetic test utilizes Next-Generation Sequencing (NGS) technology, which allows us to analyze multiple genes simultaneously. By sequencing the CRBN gene, we can identify any mutations or variations that may be present. This information is crucial for confirming a diagnosis and understanding the specific genetic cause of the condition.

NGS genetic testing is particularly beneficial for individuals with suspected MRT2 and their families. It provides a comprehensive understanding of the genetic basis of the condition, which can be useful for genetic counseling, family planning, and potentially guiding treatment decisions in the future.

It is important to note that NGS genetic testing may not be available in all healthcare settings and can vary in terms of the specific genes analyzed and the depth of sequencing performed. We recommend consulting with a healthcare professional or genetic counselor to determine the most appropriate testing approach for your specific situation.

Test Components and Price

  • Test Name: CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test
  • Price: 4400.0 AED

Sample Condition

We accept the following sample conditions for the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test:

  • Blood
  • Extracted DNA
  • One drop of blood on FTA Card

Report Delivery

Your test results will be delivered within 3 to 4 weeks.

Test Type and Department

  • Test Type: Neurological Disorders
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test, we recommend providing the following:

  • Clinical History of the Patient
  • A Genetic Counselling session to draw a pedigree chart of family members affected with CRBN Gene Mental Retardation Autosomal Recessive Type 2

Conclusion

If you suspect that you or a loved one may have mental retardation caused by mutations in the CRBN gene, our CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test can provide valuable insights. By understanding the specific genetic cause of the condition, you can make informed decisions regarding genetic counseling, family planning, and potential treatment options. Contact us today to learn more or schedule an appointment.

Test Name CRBN Gene Mental retardation autosomal recessive type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CRBN Gene Mental retardation, autosomal recessive type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with CRBN Gene Mental retardation, autosomal recessive type 2
Test Details

The CRBN gene is associated with mental retardation, autosomal recessive type 2 (MRT2). MRT2 is a rare genetic disorder characterized by intellectual disability and developmental delay. It is inherited in an autosomal recessive manner, which means that an affected individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the context of MRT2, NGS genetic testing can be used to identify mutations or variations in the CRBN gene, which can help confirm a diagnosis and provide information about the specific genetic cause of the condition.

NGS genetic testing can be beneficial for individuals with suspected MRT2 and their families, as it can provide a more comprehensive understanding of the genetic basis of the condition. This information can be useful for genetic counseling, family planning, and potentially guiding treatment decisions in the future.

It is important to note that NGS genetic testing may not be available in all healthcare settings and can vary in terms of the specific genes analyzed and the depth of sequencing performed. Therefore, it is recommended to consult with a healthcare professional or genetic counselor to determine the most appropriate testing approach for an individual’s specific situation.